Allen Anthony Wetzel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 246 S Main St, Hughesville, PA 17737 Phone: 570-584-5144 Fax: 570-584-5416 |
Quinn Kirk, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 246 S Main St, Hughesville, PA 17737 Phone: 570-584-5144 Fax: 570-584-5416 |
Laurie A Jenkins, P.A. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 106 Route 118 Hwy, Hughesville, PA 17737 Phone: 949-274-0938 |
Michael Alan Gross, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 757 Pine Tree Rd, Hughesville, PA 17737 Phone: 570-584-3324 |
News Archive
1 million abortion-rights supporters flooded the National Mall in Washington today to show their support for abortion rights, loudly identifying President Bush as the leading enemy of reproductive freedom.
Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biotherapeutics company developing a proprietary breakthrough product class of targeted oncolytic virus therapeutics, today announced that the European Medicines Agency (EMEA) has granted Orphan Drug Designation to Jennerex's product JX-594 for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer. JX-594 is expected to enter a Phase 3 pivotal trial in the second half of 2010.
MedAssurant Inc., a leading provider of data-driven healthcare solutions, today announced that it has entered into a definitive agreement with the National Committee for Quality Assurance, the organization that maintains the Healthcare Effectiveness Data and Information Set (HEDIS ®)—the most widely used performance measurement tool in healthcare and a core component of the Medicare Star Rating system—to support the development of new measures of healthcare quality that NCQA is developing under a contract it has with the Centers for Medicare & Medicaid Services.
Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 (Cytarabine:Daunorubicin) Liposome Injection. Data were presented from the podium at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.
Deep brain stimulation has been used to treat Parkinson's disease symptoms for 25 years, but limitations have led researchers to look for ways to improve the technique.
› Verified 6 days ago